Description: Eco Animal Health Group plc is engaged in the development, registration and marketing of pharmaceutical products for global animal health markets. The Company's principal activity is the manufacture and supply of animal health products across the globe. These activities are conducted on a global scale, through a network, including both regional offices (notably in Shanghai and Princeton) and overseas subsidiaries. The Company's products include Aivlosin and Ecomectin. Aivlosin is an antibiotic that treats a range of specific enteric (gut) and respiratory diseases in pigs and poultry. Ecomectin is an endectocide that controls worms, ticks, lice and mange in grazing stock and pigs. It operates in the United Kingdom and Europe, the Far East, Latin America, North America, and the Middle East and Africa. Its subsidiaries include Eco Animal Health Limited and ECO Animal Health do Brasil Comercio de Produtos Veterinarios Ltda.
Home Page: www.ecoanimalhealthgroupplc.com
EAH Technical Analysis
78 Coombe Road
New Malden,
KT3 4QS
United Kingdom
Phone:
44 20 8336 2900
Officers
| Name | Title |
|---|---|
| Mr. Christopher Wilks ACA, BSc, F.C.A. | CFO, Fin. Director, Sec. & Director |
| Mr. David Charles Hallas | CEO & Director |
Exchange: LSE
Country: UK : United Kingdom
Currency: Pence sterling (p)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 18.2815 |
|---|---|
| Trailing PE: | 46.25 |
| Price-to-Book MRQ: | 0.9421 |
| Price-to-Sales TTM: | 0.9695 |
| IPO Date: | |
| Fiscal Year End: | March |
| Full Time Employees: | 221 |